Randomized, placebo-controlled trial of convalescent plasma(CP) for severe #COVID19: "no significant differences...in clinical status or overall mortality" @NEJM
"We believe the use of CP as a standard of care....should be reevaluated." nejm.org/doi/full/10.10…
"We believe the use of CP as a standard of care....should be reevaluated." nejm.org/doi/full/10.10…
And also today yet another negative trial for hydroxychloroquine as a prophylactic intervention.
The most over-studied, under-performing, repurposed drug in modern times.
nejm.org/doi/full/10.10…
The most over-studied, under-performing, repurposed drug in modern times.
nejm.org/doi/full/10.10…
Incredible. A faculty doctor @UCLAHealth @dgsomucla
says we are too cautious by demanding evidence for #COVID19 medications. And that hydroxychloroquine has strong data to support its use. That we're killing patients.
wsj.com/articles/too-m…
says we are too cautious by demanding evidence for #COVID19 medications. And that hydroxychloroquine has strong data to support its use. That we're killing patients.
wsj.com/articles/too-m…
This outrageous oped has common threads with the recent @SenRonJohnson hearing that @ashishkjha was summoned to testify for "being responsible for hundreds of thousands of deaths." Dr. Jha's essay @nytopinion on anti-science is important to reflect upon.
nytimes.com/2020/11/24/opi…
nytimes.com/2020/11/24/opi…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
